Meningococcal polysaccharide vaccine groups ACYW135 - Hualan Biological Engineering
Latest Information Update: 27 Aug 2012
At a glance
- Originator Hualan Biological Engineering
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
Most Recent Events
- 06 Dec 2011 Launched for Meningococcal group Y infections in China (SC)
- 06 Dec 2011 Launched for Meningococcal group W-135 infections in China (SC)
- 06 Dec 2011 Launched for Meningococcal group C infections in China (SC)